These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36222764)

  • 1. Prodromal α-Synucleinopathies.
    Chahine LM
    Continuum (Minneap Minn); 2022 Oct; 28(5):1268-1280. PubMed ID: 36222764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in establishing fluid biomarkers for the diagnosis and differentiation of alpha-synucleinopathies - a mini review.
    Singer W
    Clin Auton Res; 2022 Aug; 32(4):291-297. PubMed ID: 35895157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synucleinopathies.
    Lamotte G; Singer W
    Handb Clin Neurol; 2023; 196():175-202. PubMed ID: 37620069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies.
    Palermo G; Del Prete E; Bonuccelli U; Ceravolo R
    J Neurol; 2020 Dec; 267(12):3444-3456. PubMed ID: 32594302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosing multiple system atrophy at the prodromal stage.
    Xia C; Postuma RB
    Clin Auton Res; 2020 Jun; 30(3):197-205. PubMed ID: 32232688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin in synucleinopathies.
    Hsam O; Kohl Z
    Behav Brain Res; 2023 May; 445():114367. PubMed ID: 36863462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
    Bellomo G; De Luca CMG; Paoletti FP; Gaetani L; Moda F; Parnetti L
    Neurology; 2022 Aug; 99(5):195-205. PubMed ID: 35914941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infectious Agents as Potential Drivers of α-Synucleinopathies.
    Linard M; Ravier A; Mougué L; Grgurina I; Boutillier AL; Foubert-Samier A; Blanc F; Helmer C
    Mov Disord; 2022 Mar; 37(3):464-477. PubMed ID: 35040520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.
    Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG
    Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role for the microtubule-associated protein tau variant p.A152T in risk of α-synucleinopathies.
    Labbé C; Ogaki K; Lorenzo-Betancor O; Soto-Ortolaza AI; Walton RL; Rayaprolu S; Fujioka S; Murray ME; Heckman MG; Puschmann A; McCarthy A; Lynch T; Siuda J; Opala G; Rudzinska M; Krygowska-Wajs A; Barcikowska M; Czyzewski K; Sanotsky Y; Rektorová I; McLean PJ; Rademakers R; Ertekin-Taner N; Hassan A; Ahlskog JE; Boeve BF; Petersen RC; Maraganore DM; Adler CH; Ferman TJ; Parisi JE; Graff-Radford NR; Uitti RJ; Wszolek ZK; Dickson DW; Ross OA
    Neurology; 2015 Nov; 85(19):1680-6. PubMed ID: 26333800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of cardiovascular autonomic failure in the differential diagnosis of α-synucleinopathies.
    Leys F; Wenning GK; Fanciulli A
    Neurol Sci; 2022 Jan; 43(1):187-198. PubMed ID: 34817726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Protein Conformational Strains-A Key for New Diagnostic Methods of Human Diseases.
    Surguchov A
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha-synucleinopathies: Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy.
    Spillantini MG; Goedert M
    Ann N Y Acad Sci; 2000; 920():16-27. PubMed ID: 11193145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and neuropathological differences between Parkinson's disease, Parkinson's disease dementia and dementia with Lewy bodies - current issues and future directions.
    Walker L; Stefanis L; Attems J
    J Neurochem; 2019 Sep; 150(5):467-474. PubMed ID: 30892688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and neuropsychiatric profile of the synucleinopathies: Parkinson disease, dementia with Lewy bodies, and multiple system atrophy.
    Kao AW; Racine CA; Quitania LC; Kramer JH; Christine CW; Miller BL
    Alzheimer Dis Assoc Disord; 2009; 23(4):365-70. PubMed ID: 19935145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Under pressure': is there a link between orthostatic hypotension and cognitive impairment in α-synucleinopathies?
    Udow SJ; Robertson AD; MacIntosh BJ; Espay AJ; Rowe JB; Lang AE; Masellis M
    J Neurol Neurosurg Psychiatry; 2016 Dec; 87(12):1311-1321. PubMed ID: 27613160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective vulnerability in α-synucleinopathies.
    Alegre-Abarrategui J; Brimblecombe KR; Roberts RF; Velentza-Almpani E; Tilley BS; Bengoa-Vergniory N; Proukakis C
    Acta Neuropathol; 2019 Nov; 138(5):681-704. PubMed ID: 31006067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synucleinopathies.
    Coon EA; Singer W
    Continuum (Minneap Minn); 2020 Feb; 26(1):72-92. PubMed ID: 31996623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [REM Sleep Behavior Disorder and α-synucleinopathy].
    Miyamoto T; Numahata K; Ishido H; Miyamoto M
    Brain Nerve; 2020 Feb; 72(2):107-117. PubMed ID: 32036336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and Causes of Death Among People With Clinically Diagnosed Synucleinopathies With Parkinsonism: A Population-Based Study.
    Savica R; Grossardt BR; Bower JH; Ahlskog JE; Boeve BF; Graff-Radford J; Rocca WA; Mielke MM
    JAMA Neurol; 2017 Jul; 74(7):839-846. PubMed ID: 28505261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.